Previous 10 | Next 10 |
The U.S. Federal Trade Commission ((FTC)) announces that Pfizer ([[PFE]] -0.7%) and Mylan N.V. ([[MYL]] +1.1%) have agreed to agency conditions for approving the proposed combination of Pfizer's Upjohn unit and Mylan which will do business as Viatris.Citing harm to competition in 10 generic d...
Pfizer is trading at an inexpensive valuation and offers a reliable dividend with an above-average yield. The stock has some upside potential over the coming years, and combined with the dividend, total returns could be very solid. In a best-case scenario, Pfizer could be the lead...
The coronavirus vaccines are coming -- or at least the odds are looking better every day that they are. Investors who want to potentially benefit from the launches of coronavirus vaccines have plenty of options from which to choose. However, the number of low-risk leaders in the race are few. H...
The European Commission (EC) has signed off on the proposed combination of Mylan (NASDAQ: MYL ) and Pfizer's (NYSE: PFE ) Upjohn unit. More news on: Mylan N.V., Pfizer Inc., Healthcare stocks news, Merger & acquisition news, Read more ...
HERTFORDSHIRE, England and PITTSBURGH , Sept. 15, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that the Technical Board of Appeal of the European Patent Office (EPO) has held that Yeda Research and Development Company, Ltd.'s European Patent no. 2 949 335 related t...
HERTFORDSHIRE, England , PITTSBURGH and NEW YORK , Sept. 15, 2020 /PRNewswire/ -- Mylan (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the European Commission (EC) for the proposed combination of Mylan and Pfize...
FDA approves Blueprint’s GAVRETO for lung cancer Blueprint Medicines Corporation ( BPMC ) announced that the FDA has given its approval to GAVRETO for treating adult patients with metastatic rearranged during transfection fusion-positive non-small cell lung cancer. Blueprint is coll...
HERTFORDSHIRE, England and PITTSBURGH , Sept. 9, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury , together with President Rajiv Malik will present at the Morgan Stanley Virtual 18th Annual Glo...
HERTFORDSHIRE, England and PITTSBURGH , Sept. 9, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury , together with President Rajiv Malik will present at the BofA Securities Virtual Global Healthc...
Nucleic acid vaccines, which are either DNA- or RNA-based, hold significant promise in the fight against COVID-19. Pharma giant Pfizer (NYSE: PFE) and clinical-stage Moderna (NASDAQ: MRNA) are the most prominent names involved in the development of messenger RNA (mRNA) coronavirus vaccin...
News, Short Squeeze, Breakout and More Instantly...
Mylan N.V. Company Name:
MYL Stock Symbol:
NASDAQ Market:
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...